• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

σ-1受体基因敲除会增加α-突触核蛋白的聚集和磷酸化,并导致黑质中多巴胺能神经元的丧失。

Sigma-1 receptor knockout increases α-synuclein aggregation and phosphorylation with loss of dopaminergic neurons in substantia nigra.

作者信息

Hong Juan, Wang Ling, Zhang Tingting, Zhang Baofeng, Chen Ling

机构信息

State Key Lab of Reproductive Medicine, Nanjing Medical University, Nanjing, China; Department of Physiology, Nanjing Medical University, Nanjing, China.

Department of Physiology, Nanjing Medical University, Nanjing, China.

出版信息

Neurobiol Aging. 2017 Nov;59:171-183. doi: 10.1016/j.neurobiolaging.2017.08.007. Epub 2017 Aug 10.

DOI:10.1016/j.neurobiolaging.2017.08.007
PMID:28870519
Abstract

Sigma-1 receptor (σR) is expressed in dopaminergic neurons of substantia nigra. Here, we show that σR knockout (σR) mice, at age 6-12 months, appeared with age-related loss of dopaminergic neurons and decline of motor coordination. Levels of α-synuclein (αSyn) oligomers and fibrillar αSyn in substantia nigra of σR mice were age-dependently increased without the changes in αSyn monomers. The phosphorylation of αSyn monomers or oligomers in dopaminergic neurons was enhanced in σR mice. Levels of phosphorylated eIF2a and C/EBP homologous protein expression were elevated in σR mice with decline of proteasome activity. Inhibition of endoplasmic reticulum stress by salubrinal recovered the αSyn phosphorylation and proteasome activity and prevented early oligomerization of αSyn in σR mice. Rifampicin reduced the late increase of αSyn oligomers in σR mice. Rifampicin or salubrinal could reduce the loss of dopaminergic neurons in σR mice and improved their motor coordination. The results indicate that the σR deficiency through enhanced aggregation and phosphorylation of αSyn causes the loss of dopaminergic neurons leading to the decline of motor coordination.

摘要

西格玛-1受体(σR)在黑质的多巴胺能神经元中表达。在此,我们表明,6至12个月大的σR基因敲除(σR)小鼠出现了与年龄相关的多巴胺能神经元丧失和运动协调性下降。σR小鼠黑质中α-突触核蛋白(αSyn)寡聚体和纤维状αSyn的水平随年龄依赖性增加,而αSyn单体水平无变化。σR小鼠多巴胺能神经元中αSyn单体或寡聚体的磷酸化增强。σR小鼠中磷酸化eIF2a和C/EBP同源蛋白表达水平升高,同时蛋白酶体活性下降。用沙芦比诺抑制内质网应激可恢复σR小鼠中αSyn的磷酸化和蛋白酶体活性,并防止αSyn早期寡聚化。利福平可减少σR小鼠中αSyn寡聚体后期的增加。利福平或沙芦比诺可减少σR小鼠中多巴胺能神经元的丧失并改善其运动协调性。结果表明,σR缺乏通过增强αSyn的聚集和磷酸化导致多巴胺能神经元丧失,进而导致运动协调性下降。

相似文献

1
Sigma-1 receptor knockout increases α-synuclein aggregation and phosphorylation with loss of dopaminergic neurons in substantia nigra.σ-1受体基因敲除会增加α-突触核蛋白的聚集和磷酸化,并导致黑质中多巴胺能神经元的丧失。
Neurobiol Aging. 2017 Nov;59:171-183. doi: 10.1016/j.neurobiolaging.2017.08.007. Epub 2017 Aug 10.
2
Seipin deficiency in mice causes loss of dopaminergic neurons via aggregation and phosphorylation of α-synuclein and neuroinflammation.小鼠 Seipin 缺乏通过α-突触核蛋白的聚集和磷酸化以及神经炎症导致多巴胺能神经元丧失。
Cell Death Dis. 2018 May 1;9(5):440. doi: 10.1038/s41419-018-0471-7.
3
Sigma-1 receptor deficiency reduces MPTP-induced parkinsonism and death of dopaminergic neurons.σ-1受体缺乏可减轻MPTP诱导的帕金森综合征及多巴胺能神经元死亡。
Cell Death Dis. 2015 Jul 23;6(7):e1832. doi: 10.1038/cddis.2015.194.
4
14-3-3 mitigates alpha-synuclein aggregation and toxicity in the in vivo preformed fibril model.14-3-3 减轻体内预形成纤维模型中α-突触核蛋白的聚集和毒性。
Acta Neuropathol Commun. 2021 Jan 7;9(1):13. doi: 10.1186/s40478-020-01110-5.
5
Human myeloperoxidase (hMPO) is expressed in neurons in the substantia nigra in Parkinson's disease and in the hMPO-α-synuclein-A53T mouse model, correlating with increased nitration and aggregation of α-synuclein and exacerbation of motor impairment.人类髓过氧化物酶(hMPO)在帕金森病的黑质神经元中表达,也在 hMPO-α-突触核蛋白-A53T 小鼠模型中表达,与α-突触核蛋白的硝化和聚集增加以及运动障碍恶化相关。
Free Radic Biol Med. 2019 Sep;141:115-140. doi: 10.1016/j.freeradbiomed.2019.05.033. Epub 2019 Jun 6.
6
Inhibition of MPTP-induced α-synuclein oligomerization by fatty acid-binding protein 3 ligand in MPTP-treated mice.脂肪酸结合蛋白 3 配体抑制 MPTP 处理的小鼠中 α-突触核蛋白寡聚化。
Neuropharmacology. 2019 May 15;150:164-174. doi: 10.1016/j.neuropharm.2019.03.029. Epub 2019 Mar 28.
7
Sigma-1 (σ₁) receptor deficiency reduces β-amyloid(25-35)-induced hippocampal neuronal cell death and cognitive deficits through suppressing phosphorylation of the NMDA receptor NR2B.σ-1受体缺陷通过抑制N-甲基-D-天冬氨酸受体NR2B的磷酸化,减少β-淀粉样蛋白(25-35)诱导的海马神经元细胞死亡和认知缺陷。
Neuropharmacology. 2015 Feb;89:215-24. doi: 10.1016/j.neuropharm.2014.09.027. Epub 2014 Oct 5.
8
Modeling Parkinson's Disease Neuropathology and Symptoms by Intranigral Inoculation of Preformed Human α-Synuclein Oligomers.通过向黑质内注射预先形成的人源α-突触核蛋白寡聚体来模拟帕金森病神经病理学和症状。
Int J Mol Sci. 2020 Nov 12;21(22):8535. doi: 10.3390/ijms21228535.
9
Noninvasive bioluminescence imaging of α-synuclein oligomerization in mouse brain using split firefly luciferase reporters.使用分裂萤火虫荧光素酶报告基因对小鼠大脑中α-突触核蛋白寡聚化进行无创生物发光成像。
J Neurosci. 2014 Dec 3;34(49):16518-32. doi: 10.1523/JNEUROSCI.4933-13.2014.
10
Rab1A over-expression prevents Golgi apparatus fragmentation and partially corrects motor deficits in an alpha-synuclein based rat model of Parkinson's disease.Rab1A 过表达可防止高尔基器碎裂,并在基于α-突触核蛋白的帕金森病大鼠模型中部分纠正运动缺陷。
J Parkinsons Dis. 2011;1(4):373-87. doi: 10.3233/JPD-2011-11058.

引用本文的文献

1
Pharmacological and Pathological Implications of Sigma-1 Receptor in Neurodegenerative Diseases.西格玛-1受体在神经退行性疾病中的药理学和病理学意义
Biomedicines. 2025 Jun 8;13(6):1409. doi: 10.3390/biomedicines13061409.
2
The Long-Term Effects of Chronic Unpredictable Mild Stress Experienced During Adolescence Could Vary Depending on Biological Sex.青春期经历的慢性不可预测轻度应激的长期影响可能因生物性别而异。
Int J Mol Sci. 2025 Jan 31;26(3):1251. doi: 10.3390/ijms26031251.
3
Sigma 1 Receptor and Its Pivotal Role in Neurological Disorders.
西格玛1受体及其在神经疾病中的关键作用。
ACS Pharmacol Transl Sci. 2024 Dec 30;8(1):47-65. doi: 10.1021/acsptsci.4c00564. eCollection 2025 Jan 10.
4
Targeting Sigma Receptors for the Treatment of Neurodegenerative and Neurodevelopmental Disorders.针对西格玛受体治疗神经退行性和神经发育障碍。
CNS Drugs. 2023 May;37(5):399-440. doi: 10.1007/s40263-023-01007-6. Epub 2023 May 11.
5
Chaperone-Dependent Mechanisms as a Pharmacological Target for Neuroprotection.伴侣蛋白依赖的机制作为神经保护的药理学靶点。
Int J Mol Sci. 2023 Jan 3;24(1):823. doi: 10.3390/ijms24010823.
6
Sigma-1 Receptor as a Protective Factor for Diabetes-Associated Cognitive Dysfunction via Regulating Astrocytic Endoplasmic Reticulum-Mitochondrion Contact and Endoplasmic Reticulum Stress.Sigma-1 受体通过调节星形胶质细胞内质网-线粒体接触和内质网应激作为糖尿病相关认知功能障碍的保护因子。
Cells. 2023 Jan 3;12(1):197. doi: 10.3390/cells12010197.
7
NMDA and AMPA Receptors at Synapses: Novel Targets for Tau and α-Synuclein Proteinopathies.突触处的NMDA和AMPA受体:Tau蛋白病和α-突触核蛋白病的新靶点
Biomedicines. 2022 Jun 29;10(7):1550. doi: 10.3390/biomedicines10071550.
8
Sigma 1 Receptor Contributes to Astrocyte-Mediated Retinal Ganglion Cell Protection.Sigma 1 受体有助于星形胶质细胞介导的视网膜神经节细胞保护。
Invest Ophthalmol Vis Sci. 2022 Feb 1;63(2):1. doi: 10.1167/iovs.63.2.1.
9
Nasal Rifampicin Improves Cognition in a Mouse Model of Dementia with Lewy Bodies by Reducing α-Synuclein Oligomers.鼻腔利福平通过减少α-突触核蛋白寡聚体改善路易体痴呆小鼠的认知功能。
Int J Mol Sci. 2021 Aug 6;22(16):8453. doi: 10.3390/ijms22168453.
10
Sigma receptors and neurological disorders.Sigma 受体与神经疾病。
Pharmacol Rep. 2021 Dec;73(6):1582-1594. doi: 10.1007/s43440-021-00310-7. Epub 2021 Aug 5.